CRNX — Crinetics Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $9.00bn
- $7.80bn
- $7.70m
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Crinetics Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Crinetics Q2 revenue jumps on PALSONIFY launch, withdraws guidance
Brief: Crinetics Pharmaceuticals Q2 Net Income USD -120.855 Million
Vertex raises annual revenue forecast on cystic fibrosis drugs strength
U.S. RESEARCH ROUNDUP- Alliant Energy, Prog Holdings, Travelers
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Vera Therapeutics, Vera Therapeutics, Nvidia
U.S. STOCKS ON THE MOVE-Revolution Medicines, Vivani Medical, Nvidia
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Nvidia, Crinetics Pharmaceuticals, Rivian Automotive
U.S. STOCKS ON THE MOVE-Tesla, Nvidia, Rivian
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Deals of the day-Mergers and acquisitions
U.S. RESEARCH ROUNDUP- BlackRock, Eli Lilly, Goldman Sachs
Press Digest: Wall Street Journal - July 7
Crinetics soars after Vertex agrees to buy drugmaker in $10 billion deal
Brief: Vertex To Acquire Crinetics Pharmaceuticals In $10 Billion Deal
Vertex to buy Crinetics for $10 billion in rare-diseases push (updated)